Sökning: WFRF:(Baecklund Eva) > Expression of PD-1,...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04527naa a2200445 4500 | |
001 | oai:DiVA.org:uu-472740 | |
003 | SwePub | |
008 | 220419s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4727402 URI |
024 | 7 | a https://doi.org/10.3390/cancers140615092 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Hellbacher, Eriku Uppsala universitet,Reumatologi4 aut0 (Swepub:uu)erihe902 |
245 | 1 0 | a Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity |
264 | c 2022-03-15 | |
264 | 1 | b MDPI,c 2022 |
338 | a electronic2 rdacarrier | |
520 | a Simple Summary Immunotherapy blocking programmed cell death protein 1 (PD-1) and its ligands (PD-L1, PD-L2) is less effective in non-Hodgkin lymphoma (NHL) than classical Hodgkin lymphoma. However, NHL is a heterogeneous group and current research seeks to identify subgroups of NHL patients responsive to PD-1 blocking agents. Whether patients with pre-existing rheumatic diseases might constitute such a subgroup is unknown. We investigated the expression of PD-1 and its ligands in lymphoma patients with pre-existing rheumatic diseases. Our key findings include that in patients with pre-existing rheumatoid arthritis (RA) and subsequent diffuse large B-cell lymphoma, an association between RA disease severity and increased expression of PD-L1 in tumor cells was seen. This warrants further studies of the PD-1 pathway in lymphoma in other chronic inflammatory conditions. Current research seeks to identify subgroups of non-Hodgkin lymphoma (NHL) patients responsive to PD-1 blocking agents. Whether patients with pre-existing rheumatic diseases might constitute such a subgroup is unknown. We determined intratumoral expression of PD-1 and its ligands in lymphoma patients with pre-existing rheumatic diseases. We included 215 patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or Sjogren's syndrome with subsequent lymphoma and 74 diffuse large B-cell lymphoma (DLBCL) controls without rheumatic disease. PD-1 and PD-ligand immunohistochemical markers were applied on tumor tissue microarrays. The number of PD-1+ tumor infiltrating leukocytes (TILs) and proportions of PD-L1+ and PD-L2+ tumor cells and TILs were calculated and correlated with clinical data. Expression of PD-L1 in tumor cells and TILs was highest in classical Hodgkin lymphoma and DLBCL. In DLBCLs, expression of PD-1 in TILs and PD-L1 in tumor cells was similar in RA, SLE and controls. In RA-DLBCL, high expression of PD-L1 in tumor cells was significantly more common in patients with the most severe RA disease and was associated with inferior overall survival in multivariable analysis. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a lymphoma | |
653 | a PD-1 | |
653 | a PD-L1 | |
653 | a rheumatic disease | |
653 | a immunohistochemistry | |
700 | 1 | a Sundström, Christeru Uppsala universitet,Experimentell och klinisk onkologi,Klinisk och experimentell patologi,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)chrisund |
700 | 1 | a Molin, Daniel,d 1969-u Uppsala universitet,Experimentell och klinisk onkologi4 aut0 (Swepub:uu)danimoli |
700 | 1 | a Baecklund, Eva,d 1956-u Uppsala universitet,Reumatologi,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)evaba786 |
700 | 1 | a Hollander, Peteru Uppsala universitet,Experimentell och klinisk onkologi,Klinisk och experimentell patologi4 aut0 (Swepub:uu)petho189 |
710 | 2 | a Uppsala universitetb Reumatologi4 org |
773 | 0 | t Cancersd : MDPIg 14:6q 14:6x 2072-6694 |
856 | 4 | u https://doi.org/10.3390/cancers14061509y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1652665/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-472740 |
856 | 4 8 | u https://doi.org/10.3390/cancers14061509 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.